There is another important milestone in the now 74-year history of Chromos AG: Chromos AG and FUJIFILM (Switzerland) AG, which have been part of our group of companies for many years, are merging to form Chromos Group AG on 1 July 2020. Technological changes and economic challenges require ever greater flexibility in order to develop efficient and future-proof solutions as a bridge builder in the triangle with customers and suppliers.
We are proud that FUJIFILM can make a contribution to the fight against the corona virus.
FUJIFILM is in the third phase of clinical trials with the drug Avigan. These tests are designed to verify how safe and effective the antiviral drug, also known as favipiravir, really is. The clinical trials are being conducted in Japan on Covid-19 patients.
Nous souhaitons par la présente vous informer de l'état d'avancement de nos mesures visant à réduire la propagation du virus Corona et à assurer la sécurité de nos employés, clients, fournisseurs et partenaires et de leurs familles.